InvestorsHub Logo
icon url

jesster64

01/02/22 6:47 AM

#431300 RE: dennisdave #431298

well, I did see DWAC do from $9 a share to $175 in a day and a half. No fundamentals whatsoever, no product, no revenue...
icon url

improving

01/02/22 9:09 AM

#431306 RE: dennisdave #431298

Dennis, TSLA is the closest I can think of. While TSLA'a product is a luxury, NWBO's is a necessity, potentially covering multiple (many) solid tumor cancers. The number of cancer deaths each year is staggering: worldwide, 1 in 6 people will die from cancer, according to latest stats from the American Cancer Society. So, with great data, put me in the group that believes sky high valuations for NWBO are quite possible, and I believe likely. Best for the New Year, Regards.
icon url

hoffmann6383

01/02/22 9:22 AM

#431312 RE: dennisdave #431298

is there a personalized cancer vaccine for gbm and possibly all other solid tumors that may turn into SoC? nope. we can agree that we are in uncharted water